The budget impact and cost-effectiveness thresholds in the context of other criteria in reimbursement decision making of medicinal products

Charles University in Prague, Faculty of Pharmacy in Hradec Králové Social and Clinical Pharmacy Author: Duong Thuy Linh Supervisor: PharmDr. Jiří Klimeš, PhD., MBA Title of Thesis: The budget impact and cost-effectiveness thresholds in the context of other criteria in reimbursement decision making of medicinal products KEY WORDS: cost-effectiveness analysis, Willingness to pay threshold, medicines, MCDA - multi- criteria decision analysis OBJECTIVES: The aim of this study was to provide a structured overview of selected criteria that are / may be key to adopt new innovative technology in the reimbursement system, based on a retrospective analysis of selected decisions of the State Institute for Drug Control. It was investigated the relationship between the individual criteria (and scoring results) coming from the multi-criteria analysis and the value of ICER and BIA, for these medicinal products entering the reimbursed system. METHODS: Retrospective analysis of selected legally closed, published and publicly available administrative proceedings of the State Institute for Drug Control in the period January 2020 - May 2021. A total of 20 administrative proceedings were selected for the final analysis, of which 12 medicinal products that were selected, entered the permanent reimbursement and the..